ShopSpell

Data Monitoring in Clinical Trials A Case Studies Approach [Paperback]

$73.99     $99.99    26% Off      (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  0387203303
  • ISBN-10:  0387203303
  • ISBN-13:  9780387203300
  • ISBN-13:  9780387203300
  • Publisher:  Springer
  • Publisher:  Springer
  • Pages:  374
  • Pages:  374
  • Binding:  Paperback
  • Binding:  Paperback
  • Pub Date:  01-Feb-2005
  • Pub Date:  01-Feb-2005
  • SKU:  0387203303-11-SPRI
  • SKU:  0387203303-11-SPRI
  • Item ID: 100752694
  • List Price: $99.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Jul 16 to Jul 18
  • Notes: Brand New Book. Order Now.

From the authors of Fundamentals of Clinical Trials which has sold over 15,000 copies world wide since its publication in 1998.

No competition yet as the text does not focus on how to do clinical trials but on very specific situations that can be encountered during the process.

Randomized clinical trials are the gold standard for establishing many clinical practice guidelines and are central to evidence based medicine. Obtaining the best evidence through clinical trials must be done within the boundaries of rigorous science and ethical principles. One fundamental principle is that trials should not continue longer than necessary to reach their objectives. Therefore, trials must be monitored for recruitment progress, quality of data, adherence to patient care or prevention standards, and early evidence of benefit or harm. Frequently, a group of external experts, independent from the investigators and trial sponsor, is charged with this monitoring responsibility, especially for safety and early benefit. This group is referred to by various names, such as a data monitoring committee or a data and safety monitoring board. This book, through a series of case studies presented by many distinguished clinical trial experts, illustrates the complexity of this monitoring process. The editors provide an overview of the process and a summary of a multitude of the lessons learned from the cases presented.

This book should be useful to anyone serving on a data and safety monitoring board, or planning to do so, for colleagues in academia, industry and governmental agencies, and for teaching students in biostatistics, epidemiology, clinical trials and medical ethics. No other text has as extensive a collection of cases which provide insight into the many issues, often conflicting, that must be examined before recommendations to continue or discontinue a trial can be made. While depth in statistical methods is not requls¢

Add Review